Three-dimensional blood-brain barrier cell and tissue culture system

• US 5,578,485 A
• Filed: 04/06/1995
• Issued: 11/26/1996
• Est. Priority Date: 04/18/1986
• Status: Expired due to Fees

• Current Assignee: Smith & Nephew Wound Management (Smith & Nephew PLC)
• Original Assignee: Advanced Tissue Sciences, Inc.
• Inventors: Naughton, Gail K., Naughton, Brian A.
• Primary Examiner(s): Czaja, Donald E.
• Assistant Examiner(s): WILLIAMS, JANE
• Application Number:
  US08/418,237
• Time in Patent Office: 600 Days
• Field of Search: 424/95, 424/177, 424/93, 424/529, 424/530, 424/534, 424/572, 424/574, 424/484, 424/422, 435/32, 435/29, 435/1, 435/240.23, 435/240.243, 435/240.1, 435/240.2, 435/284, 436/63
• US Class Current: 435/32
• CPC Class Codes: A61B 2010/0258 Marrow samples
• CPC Class Codes: A61B 90/00 Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges protective face masks A41D13/11; surgeon's or patient's gowns or dresses A41D13/12; devices for carrying-off, for treatment of, or for carrying-over, body liquids A61M1/00
• CPC Class Codes: A61K 2035/124 the cells being hematopoietic, bone marrow derived or blood cells
• CPC Class Codes: A61K 35/12 Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells vaccines or medicinal preparations containing antigens or antibodies A61K39/00
• CPC Class Codes: A61K 35/28 Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
• CPC Class Codes: A61L 27/3604 characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
• CPC Class Codes: A61L 27/3886 comprising two or more cell types
• CPC Class Codes: A61L 27/60 Materials for use in artificial skin
• CPC Class Codes: C12N 2500/34 Sugars
• CPC Class Codes: C12N 2501/11 Epidermal growth factor [EGF]
• CPC Class Codes: C12N 2501/33 Insulin together with transferrin C12N2500/25; Insulin-like growth factors C12N2501/105
• CPC Class Codes: C12N 2501/335 Glucagon; Glucagon-like peptide [GLP]; Exendin
• CPC Class Codes: C12N 2501/39 Steroid hormones
• CPC Class Codes: C12N 2502/091 melanocytes
• CPC Class Codes: C12N 2502/094 keratinocytes
• CPC Class Codes: C12N 2502/1323 Adult fibroblasts
• CPC Class Codes: C12N 2503/04 Screening or testing on artificial tissues
• CPC Class Codes: C12N 2510/00 Genetically modified cells
• CPC Class Codes: C12N 2533/30 Synthetic polymers thermoreactive polymers, e.g. PNIPAm, C12N2539/10
• CPC Class Codes: C12N 2533/40 Polyhydroxyacids, e.g. polymers of glycolic or lactic acid (PGA, PLA, PLGA); Bioresorbable polymers
• CPC Class Codes: C12N 2533/70 : Polysaccharides
• CPC Class Codes: C12N 5/0698 : Skin equivalents
• CPC Class Codes: Y10S 623/915 : Method or apparatus for preparing biological material

Abstract

The present invention relates to a three-dimensional cell culture system which can be used to culture a variety of different cells and tissues in vitro for prolonged periods of time. In accordance with the invention, cells derived from a desired tissue are inoculated and grown on a pre-established stromal support matrix. The stromal support matrix comprises stromal cells, such as fibroblasts actively growing on a three-dimensional matrix. Stromal cells may also include other cells found in loose connective tissue such as endothelial cells, macrophages/monocytes, adipocytes, pericytes, reticular cells found in bone marrow stroma, etc. The stromal matrix provides the support, growth factors, and regulatory factors necessary to sustain long-term active proliferation of cells in culture. When grown in this three-dimensional system, the proliferating cells mature and segregate properly to form components of adult tissues analogous to counterparts found in vivo.

Claims

1. A three-dimensional blood-brain barrier cell culture system, comprising neuron cells and astrocytes cultured on a living stromal tissue prepared in vitro, said living stromal tissue comprising confluent small blood vessel endothelial cells attached to and substantially enveloping a framework composed of a biocompatible, non-living material formed into a three-dimensional structure having interstitial spaces bridged by the endothelial cells.

2. The three-dimensional cell culture of claim 1 in which the framework is composed of a biodegradable material.

3. The three-dimensional cell culture of claim 2 in which the biodegradable material is cotton, polyglycolic acid, cat gut sutures, cellulose, gelatin, or dextran.

4. The three-dimensional cell culture of claim 1 in which the framework is composed of a non-biodegradable material.

5. The three-dimensional cell culture of claim 4 in which the non-biodegradable material is a polyamide, a polyester, a polystyrene, a polypropylene, a polyacrylate, a polyvinyl, a polycarbonate, a polytetrafluorethylene, or a nitrocellulose compound.

6. The three-dimensional cell culture of claim 2, 3, 4 or 5 in which the framework is pre-coated with collagen.

7. The three-dimensional cell culture of claim 1, 2, 3, 4 or 5 in which the framework is a mesh.

8. The three-dimensional cell culture of claim 6 in which the framework is a mesh.

9. A method for culturing blood-brain barrier cell cultures in vitro, comprising:

(a) culturing astrocytes inoculated onto a living stromal tissue prepared in vitro, said living stromal tissue comprising confluent endothelial cells inoculated on a three-dimensional framework so that the confluent endothelial cells attach to and substantially envelope the framework composed of a biocompatible, non-living material formed into a three-dimensional structure having interstitial spaces bridged by the endothelial cells; and

further

(b) inoculating further onto said astrocytes, neuron cells.

10. The method according to claim 9 in which the framework is composed of a biodegradable material.

11. The method according to claim 10 in which the biodegradable material is cotton, polyglycolic acid, cat gut sutures, cellulose, gelatin, or dextran.

12. The method according to claim 9 in which the framework is composed of a non-biodegradable material.

13. The method according to claim 12 in which the non-biodegradable material is a polyamide, a polyester, a polystyrene, a polypropylene, a polyacrylate, a polyvinyl, a polycarbonate, a polytetrafluorethylene, or a nitrocellulose compound.

14. The method according to claim 10, 11, 12 or 13 in which the framework is pre-coated with collagen.

15. The method according to claim 9, 10, 11, 12 or 13 in which the framework is a mesh.

16. The method according to claim 14 in which the framework is a mesh.

17. A method for transplantation or implantation of a three-dimensional blood-brain barrier cell culture comprising implanting in vivo neuron cells and astrocytes cultured on a living stromal tissue prepared in vitro, said living stromal tissue comprising confluent small blood vessel endothelial cells attached to and substantially enveloping a framework composed of a biocompatible, non-living material formed into a three-dimensional structure having interstitial spaces bridged by the endothelial cells so that a tissue equivalent is formed.

18. The method according to claim 17 in which the framework is composed of a biodegradable material.

19. The method according to claim 18 in which the biodegradable material is cotton, polyglycolic acid, cat gut sutures, cellulose, gelatin, or dextran.

20. The method according to claim 17 in which the framework is composed of a non-biodegradable material.

21. The method according to claim 20 in which the non-biodegradable material is a polyamide, a polyester, a polystyrene, a polypropylene, a polyacrylate, a polyvinyl, a polycarbonate, a polytetrafluorethylene, or a nitrocellulose compound.

22. The method according to claim 18, 19, 20 or 21 in which the framework is pre-coated with collagen.

23. The method according to claim 17, 18, 19, 20 or 21 in which the framework is a mesh.

24. The method according to claim 22 in which the framework is a mesh.

25. A method for determining the effect of a drug on neuronal cells or astrocytes cells in culture comprising:

(a) exposing a three-dimensional blood-brain barrier cell culture to the drug, in which the three-dimensional cell culture comprises neuron cells and astrocytes grown on a living stromal tissue prepared in vitro, said living stromal tissue comprising confluent small blood vessel endothelial cells attached to and substantially enveloping a framework composed of a biocompatible, non-living material formed into a three-dimensional structure having interstitial spaces bridged by the endothelial cells; and

(b) determining the effect of the drug on the neuronal cells or astrocyte cells in culture.

26. The method for determining the effect of a drug according to claim 25 in which the framework is composed of a biodegradable material.

27. The method for determining the effect of a drug according to claim 26 in which the biodegradable material is cotton, polyglycolic acid, cat gut sutures, cellulose, gelatin, or dextran.

28. The method for determining the effect of a drug according to claim 25 in which the framework is composed of a non-biodegradable material.

29. The method for determining the effect of a drug according to claim 28 in which the non-biodegradable material is a polyamide, a polyester, a polystyrene, a polypropylene, a polyacrylate, a polyvinyl, a polycarbonate, a polytetrafluorethylene, or a nitrocellulose compound.

30. The method for determining the effect of a drug according to claim 26, 27, 28 or 29 in which the framework is pre-coated with collagen.

31. The method according to claim 25, 26, 27, 28 or 29 in which the framework is a mesh.

32. The method according to claim 30 in which the framework is a mesh.

33. A method for studying the mechanism of a disease or condition in a patient, which disease or condition has a detectable effect on neuronal cells or astrocytes comprising:

(a) inoculating astrocytes from a sample obtained from the patient onto a living stromal tissue prepared in vitro, said living stromal tissue comprising confluent endothelial cells attached to and substantially enveloping a framework composed of a biocompatible, non-living material formed into a three-dimensional structure having interstitial spaces bridged by the endothelial cells;

(b) inoculating further onto said astrocytes neuron cells obtained from the patient;

(c) culturing the inoculated living stromal tissue in a nutrient medium so that the inoculated astrocytes and neuron cells proliferate in culture; and

(d) analyzing the proliferated cells in culture for markers of the disease or condition.

34. The method according to claim 33 in which the framework is composed of a biodegradable material.

35. The method according to claim 34 in which the biodegradable material is cotton, polyglycolic acid, cat gut sutures, cellulose, gelatin, or dextran.

36. The method according to claim 33 in which the framework is composed of a non-biodegradable material.

37. The method according to claim 36 in which the non-biodegradable material is a polyamide, a polyester, a polystyrene, a polypropylene, a polyacrylate, a polyvinyl, a polycarbonate, a polytetrafluorethylene, or a nitrocellulose compound.

38. The method according to claim 34, 35, 36 or 37 in which the framework is pre-coated with collagen.

39. The method according to claim 33, 34, 35, 36 or 37 in which the framework is a mesh.

40. The method according to claim 38 in which the framework is a mesh.

41. A method for testing the ability of a substance to cross a blood-brain barrier comprising:

(a) exposing an amount of the substance which has a detectable effect on the astrocytes or neuron cells to the endothelial surface of a three-dimensional culture system comprising astrocytes and neuron cells grown on a living stromal tissue prepared in vitro, said living stromal tissue comprising confluent endothelial cells attached to and substantially enveloping a framework composed of a biocompatible, non-living material formed into a three-dimensional structure having interstitial spaces bridged by the endothelial cells; and

(b) detecting the effect of the substance on the astrocytes or neuron cells of the inoculated three-dimensional stromal matrix.